Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Psychiatr Pract ; 28(6): 497-504, 2022 11 01.
Article in English | MEDLINE | ID: mdl-36355590

ABSTRACT

OBJECTIVE: Long-acting injectable antipsychotics (LAI-As) are a crucial treatment option for individuals with serious mental illness. However, due to the necessity of in-person administration of LAI-As, pandemics pose unique challenges for continuity of care in the population prescribed these medications. This project investigated the impact of the coronavirus disease 2019 (COVID-19) pandemic on LAI-A adherence at a Veterans Health Administration medical facility in the United States, as well as changes in LAI-A prescribing and administration practices during this period. METHODS: Electronic health records were evaluated for 101 patients prescribed LAI-As. A subset of 13 patients also participated in an interview and rated subjective concerns about pandemic-related barriers to medication adherence. RESULTS: Pandemic-related barriers to LAI-A adherence and/or changes to LAI-A medications were documented in 33% of the patients. Within-subjects comparison of an adherence metric computed from electronic health record data further suggested a somewhat higher incidence of missed or delayed LAI-A doses during the pandemic compared with before the pandemic. In contrast, only 2 of the 13 patients interviewed anticipated that pandemic-related concerns would interfere with medication adherence. CONCLUSIONS: The results of this study suggest that LAI-A access and adherence can be disrupted by pandemics and other public health emergencies but this finding may not generalize to other sites. As patients may not foresee the potential for disruption, psychiatric service providers may need to assist in proactively problem-solving barriers to access. Improved preparedness and additional safeguards against pandemic-related disruptions to LAI-A access and adherence may help mitigate adverse outcomes in the future. Identifying patients at elevated risk for such disruptions may help support these efforts.


Subject(s)
Antipsychotic Agents , COVID-19 , Schizophrenia , Humans , United States , Antipsychotic Agents/therapeutic use , Pandemics , Schizophrenia/drug therapy , Delayed-Action Preparations/therapeutic use , Injections , Medication Adherence
2.
Clin Nurse Spec ; 18(1): 16-20, 2004.
Article in English | MEDLINE | ID: mdl-15061443

ABSTRACT

One way clinical nurse specialists (CNS) influence nursing practice and share professional expertise is by making presentations. This article presents strategies that clinical nurse specialists can use to enhance the effectiveness of oral presentations. Included are tips for analyzing the audience, developing content and materials, selecting presentation methods, and delivering an effective presentation.


Subject(s)
Nurse Clinicians , Speech , Teaching/methods , Audiovisual Aids , Humans , Kinesics , Needs Assessment , Pamphlets , Teaching Materials , Verbal Behavior
SELECTION OF CITATIONS
SEARCH DETAIL
...